1280332

Supernus Pharmaceuticals, Inc. — FEI 3005209462

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)